Total (n = 739) | No MI, unstable angina, PCI or CABG (before 20,140,830) (n = 642) | MI, unstable angina, PCI or CABG (before 20,140,830) (n = 97) | p value | |
---|---|---|---|---|
Framingham score | 11.0 (2.2) 11.0 (5.0; 18.0) n = 707 | 10.9 (2.1) 11.0 (5.0; 17.0) n = 616 | 12.3 (2.1) 12.0 (7.0; 18.0) n = 91 | < .0001 |
Total cholesterol (mmol/L) | 5.88 (1.04) 5.80 (3.10; 9.90) n = 739 | 5.83 (1.03) 5.80 (3.10; 9.10) n = 642 | 6.19 (0.99) 6.00 (4.20; 9.90) n = 97 | 0.0043 |
Hyperlipidemia | 263 (35.6%) | 222 (34.6%) | 41 (42.3%) | 0.18 |
HDL cholesterol | 1.31 (0.34) 1.30 (0.57; 3.70) n = 710 | 1.33 (0.34) 1.30 (0.57; 3.70) n = 619 | 1.16 (0.31) 1.10 (0.58; 2.40) n = 91 | < .0001 |
Systolic blood pressure (mmHg) | 128.9 (17.3) 128.0 (92.0; 198.0) n = 736 | 128.0 (17.0) 126.0 (92.0; 198.0) n = 639 | 134.4 (17.9) 135.0 (92.0; 178.0) n = 97 | 0.0003 |
Diastolic blood pressure (mmHg) | 84.4 (10.6) 84.0 (56.0; 120.0) n = 736 | 83.9 (10.5) 82.0 (56.0; 120.0) n = 639 | 87.3 (11.0) 88.0 (62.0; 110.0) n = 97 | 0.0027 |
Hypertension | 291 (39.4%) | 235 (36.6%) | 56 (57.7%) | 0.0001 |
Blood pressure lowering medication | 44 (6.0%) | 29 (4.5%) | 15 (15.5%) | 0.0004 |
Smoker | 228 (30.9%) | 191 (29.8%) | 37 (38.1%) | 0.12 |
BMI (kg/m2) | 26.2 (3.4) 25.8 (16.6; 41.6) n = 739 | 26.1 (3.4) 25.7 (16.6; 41.6) n = 642 | 27.0 (3.6) 26.7 (18.5; 38.3) n = 97 | 0.022 |
Fasting plasma glucose (mmol/L) | 4.67 (1.26) 4.50 (2.60; 19.20) n = 736 | 4.63 (1.16) 4.50 (2.60; 19.20) n = 639 | 4.95 (1.80) 4.60 (3.80; 17.60) n = 97 | 0.0059 |
Diabetes | 25 (3.4%) | 20 (3.1%) | 5 (5.2%) | 0.44 |
Sedentary leisure time | 112 (15.2%) | 92 (14.3%) | 20 (20.6%) | 0.15 |
High-sensitivity C-reactive Protein (mg/L) | 2.26 (3.60) 1.23 (0.14; 47.06) n = 739 | 2.22 (3.47) 1.21 (0.14; 47.06) n = 642 | 2.51 (4.40) 1.41 (0.16; 40.25) n = 97 | 0.12 |
hsCRP > 1 mg/L | 448 (60.6%) | 378 (58.9%) | 70 (72.2%) | 0.015 |
hsCRP > 2 mg/L | 240 (32.5%) | 207 (32.2%) | 33 (34.0%) | 0.81 |
hsCRP > 3 mg/L | 135 (18.3%) | 118 (18.4%) | 17 (17.5%) | 0.97 |
NT-proBNP (pg/mL) | 33.9 (40.7) 23.7 (5.0; 375.2) n = 739 | 33.8 (40.1) 24.0 (5.0; 375.2) n = 642 | 34.3 (44.8) 22.1 (5.0; 291.4) n = 97 | 0.98 |
NT-proBNP > 50 pg/mL | 132 (17.9%) | 117 (18.2%) | 15 (15.5%) | 0.62 |
NT-proBNP > 100 pg/mL | 41 (5.5%) | 36 (5.6%) | 5 (5.2%) | 1.00 |
High-sensitivity Troponin-T (ng/L) | 5.07 (3.30) 4.04 (3.00; 38.96) n = 739 | 4.97 (3.10) 3.98 (3.00; 37.20) n = 642 | 5.67 (4.35) 4.49 (3.00; 38.96) n = 97 | 0.041 |
hsTroponin-T > 3 ng/L | 507 (68.6%) | 431 (67.1%) | 76 (78.4%) | 0.032 |
hsTroponin-T > 5 ng/L | 265 (35.9%) | 225 (35.0%) | 40 (41.2%) | 0.28 |
hsTroponin-T > 10 ng/L | 39 (5.3%) | 29 (4.5%) | 10 (10.3%) | 0.045 |
IL-6 (ng/L) | 2.77 (3.90) 1.88 (1.50; 87.10) n = 736 | 2.70 (3.84) 1.84 (1.50; 87.10) n = 641 | 3.21 (4.26) 2.25 (1.50; 36.61) n = 95 | 0.023 |
IL-6 > 8 ng/L | 19 (2.6%) | 16 (2.5%) | 3 (3.2%) | 0.91 |
Number of risk biomarkers (hsCRP > 1,NT-proBNP > 100,hsTroponin-T > 10,IL6 > 8) | ||||
0 | 264 (35.7%) | 240 (37.4%) | 24 (24.7%) | |
1 | 408 (55.2%) | 349 (54.4%) | 59 (60.8%) | |
2 | 62 (8.4%) | 49 (7.6%) | 13 (13.4%) | |
3 | 5 (0.7%) | 4 (0.6%) | 1 (1.0%) | 0.0053 |